Primary and secondary outcomes at patient level in the intervention and control group
| patients | |||||
| Outcomes | Instrument | Items | T1 Baseline | T2 3 months | T3 6 months follow-up |
| Primary outcome | |||||
| Patient activation | PAM-13 | 13 | x | x | x |
| Secondary outcomes | |||||
| Health status | EQ-5D | 5 | x | x | x |
| Self-efficacy | SES6G | 6 | x | x | x |
| Unmet needs | NEQ | 27 | x | ||
| Quality of life | EORTC-QLQ-C30 (only question 29+30) | 2 | x | x | x |
| Depression, agitation | PHQ-9 | 9 | x | x | x |
| Fatique | EORTC-QLQ-FA12 | 12 | x | x | x |
| Measure yourself concerns and well-being | MYCaW | 7 | x | x | x |
| Symptoms, therapy assisted | MIDOS2 | 11 | x | x | x |
| Single item literacy screener | SILS | 1 | x | ||
| Healthcare Utilisation Questionnaire | HCU-Q (adapted) | 11 | x | x | x |
| Sociodemographic data | 26 | x | |||
| Medical data | 10 | x | x | x | |
EORTC-QLQ-C30, European Organisation for Research and Treatment of Cancer - Quality of Life of Cancer Patients Questionnaire - Core; EORTC-QLQ-FA12, European Organization for Research and Treatment of Cancer - Quality of Life of Cancer Patients Questionnaire - Cancer Related Fatigue; EQ-5D, European Quality of Life 5 Dimensions; HCU, Healthcare Utilisation Questionnaire; MIDOS2, Minimal Documentation System; MYCaW, Measure Yourself Concerns and Wellbeing; NEQ, Needs Evaluation Questionnaire; PAM-13, Patient Activation Measure 13; PHQ-9, Patient Health Questionnaire; SES6G, Self-Efficacy for Managing Chronic Disease 6-Item Scale; SILS, Single Item Literacy Screener.